Fig. 8From: Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulationImprovement in “ganglion cell complex thickness” according to study timepoints (T0, T2) in the OD eye treated with combination of WJ-MSC and rEMS (Table 1, patient 5: right eye. (a) Before application, 94 µm, (b) at 4th month, 60 µm. Improvement in “ganglion cell complex thickness” according to study timepoints (T0, T2) in the OS eye treated with only rEMS (Table 2, patient 5: left eye. (a) Before application, 89 µm, (b) at 4th month, 64 µmBack to article page